Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
28,000
Employees28,000
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
28,000
Employees28,000

AMGN Key Statistics

Market cap
179.24B
Market cap179.24B
Price-Earnings ratio
25.82
Price-Earnings ratio25.82
Dividend yield
2.85%
Dividend yield2.85%
Average volume
3.48M
Average volume3.48M
High today
$333.98
High today$333.98
Low today
$330.87
Low today$330.87
Open price
$333.65
Open price$333.65
Volume
755.84K
Volume755.84K
52 Week high
$346.38
52 Week high$346.38
52 Week low
$257.05
52 Week low$257.05

Stock Snapshot

Amgen(AMGN) stock is priced at $332.93, giving the company a market capitalization of 179.24B. It carries a P/E multiple of 25.82 and pays a dividend yield of 2.9%.

As of 2025-12-26, Amgen(AMGN) stock has fluctuated between $330.87 and $333.98. The current price stands at $332.93, placing the stock +0.6% above today's low and -0.3% off the high.

Amgen(AMGN) shares are trading with a volume of 755.84K, against a daily average of 3.48M.

In the last year, Amgen(AMGN) shares hit a 52-week high of $346.38 and a 52-week low of $257.05.

In the last year, Amgen(AMGN) shares hit a 52-week high of $346.38 and a 52-week low of $257.05.

AMGN News

Simply Wall St 4d
Is There Still Value in Amgen After Its Strong 2025 Share Price Run?

Wondering if Amgen’s share price already reflects the upside, or if there is still value on the table? You are not alone, and this article is going to tackle th...

Is There Still Value in Amgen After Its Strong 2025 Share Price Run?
TipRanks 4d
Amgen’s Pediatric Inebilizumab Study Signals Long-Term Upside in Rare Autoimmune Disease

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data a...

TipRanks 4d
Amgen’s Long-Term Pediatric Psoriasis Study on Apremilast: Why the Latest Update Matters for Investors

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data a...

Analyst ratings

45%

of 31 ratings
Buy
45.2%
Hold
45.2%
Sell
9.7%

More AMGN News

TipRanks 6d
Schwab US Dividend Equity ETF Sees Inflows Amid Weekly Decline

Schwab US Dividend Equity ETF ( $SCHD ) has fallen by 1.08% in the past week. It has experienced a 5-day net inflow of $1.41 billion. This is due, in part, to...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.